Keyphrases
Epilepsy
100%
Population-based
100%
Genetic Testing
100%
Cost-effectiveness Study
100%
Etiology
71%
Cost-effectiveness
42%
Electroencephalography
28%
Metabolic
14%
Early Diagnosis
14%
Brain Malformation
14%
Precision Medicine
14%
Seizure
14%
Medical Records
14%
Population-based Study
14%
Antiepileptic Drugs
14%
Economic Burden
14%
Channelopathy
14%
Unknown Etiology
14%
Gene Panel
14%
Genetic Diagnosis
14%
Caregiver Burden
14%
Diagnostic Performance
14%
Seizure Onset
14%
Live Birth
14%
Diagnostic Pathway
14%
Optimal Management
14%
Early Use
14%
Acquired Brain Injury
14%
Epilepsy Onset
14%
Whole Exome
14%
Cost-effectiveness Ratio
14%
Economic Modeling
14%
Timely Administration
14%
Focal Cortical Dysplasia
14%
Epileptiform
14%
Metabolic Testing
14%
Additional Diagnosis
14%
Medicine and Dentistry
Infancy
100%
Genetic Screening
100%
Effectiveness Study
100%
Cost-Effectiveness Analysis
100%
Health Care Cost
66%
Diseases
33%
Diagnosis
33%
Epileptic Seizure
33%
Magnetic Resonance Imaging
16%
Acquired Brain Injury
16%
Anticonvulsant
16%
Personalized Medicine
16%
Channelopathy
16%
Cortical Dysplasia
16%
Brain Malformation
16%
Childbirth
16%
Medical Record
16%
Early Diagnosis
16%
Exome
16%
Biochemistry, Genetics and Molecular Biology
Effectiveness Study
100%
Genetic Screening
100%
Infancy
100%
Genetics
33%
Exome
16%
Dysplasia
16%
Medical Record
16%
Channelopathy
16%